{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:19:29Z","timestamp":1791839969824,"version":"4.3.4"},"update-to":[{"DOI":"10.1002\/14651858.cd010315.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T00:00:00Z","timestamp":1668729600000}}],"reference-count":120,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010315.pub5","type":"journal-article","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T13:03:17Z","timestamp":1668776597000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Blood pressure targets for the treatment of people with hypertension and cardiovascular disease"],"prefix":"10.1002","volume":"2022","author":[{"given":"Luis Carlos","family":"Saiz","sequence":"additional","affiliation":[{"name":"Unit of Innovation and Organization; Navarre Health Service; Pamplona Spain"},{"name":"Navarre Institute for Health Research (IdiSNA); Pamplona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Gorricho","sequence":"additional","affiliation":[{"name":"Navarre Institute for Health Research (IdiSNA); Pamplona Spain"},{"name":"Healthcare Business Intelligence Service; Navarre Health Service; Pamplona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Garj\u00f3n","sequence":"additional","affiliation":[{"name":"Navarre Institute for Health Research (IdiSNA); Pamplona Spain"},{"name":"Medicines Advice and Information Service; Navarre Health Service; Pamplona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00aa Concepci\u00f3n","family":"Celaya","sequence":"additional","affiliation":[{"name":"Navarre Institute for Health Research (IdiSNA); Pamplona Spain"},{"name":"Drug Prescribing Service; Navarre Health Service; Pamplona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Erviti","sequence":"additional","affiliation":[{"name":"Unit of Innovation and Organization; Navarre Health Service; Pamplona Spain"},{"name":"Navarre Institute for Health Research (IdiSNA); Pamplona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leire","family":"Leache","sequence":"additional","affiliation":[{"name":"Unit of Innovation and Organization; Navarre Health Service; Pamplona Spain"},{"name":"Navarre Institute for Health Research (IdiSNA); Pamplona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,11,18]]},"reference":[{"issue":"23","key":"10.1002\/14651858.CD010315.pub5-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1001\/jama.295.23.2726-c","article-title":"Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial \u2013 correction","volume":"295","year":"2006","journal-title":"JAMA"},{"issue":"7 Suppl 2","key":"10.1002\/14651858.CD010315.pub5-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"S166","DOI":"10.1097\/01.ASN.0000070081.15137.C0","article-title":"The rationale and design of the AASK cohort study","volume":"14","author":"Appel","year":"2003","journal-title":"Journal of the American Society of Nephrology"},{"issue":"7 Suppl 2","key":"10.1002\/14651858.CD010315.pub5-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1097\/01.ASN.0000070080.21680.CB","article-title":"Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK)","volume":"14","author":"Gassman","year":"2003","journal-title":"Journal of the American Society of Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD010315.pub5-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1053\/j.ajkd.2006.08.004","article-title":"Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) trial","volume":"48","author":"Norris","year":"2006","journal-title":"American Journal of Kidney Diseases"},{"issue":"19","key":"10.1002\/14651858.CD010315.pub5-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1001\/jama.288.19.2421","article-title":"Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial","volume":"288","author":"Bakris","year":"2002","journal-title":"JAMA"},{"issue":"17","key":"10.1002\/14651858.CD010315.pub5-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus","volume":"362","author":"Cushman","year":"2010","journal-title":"New England Journal of Medicine"},{"issue":"12A","key":"10.1002\/14651858.CD010315.pub5-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"21i","DOI":"10.1016\/j.amjcard.2007.03.003","article-title":"Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods","volume":"99","author":"Buse","year":"2007","journal-title":"American Journal of Cardiology"},{"issue":"12A","key":"10.1002\/14651858.CD010315.pub5-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"44i","DOI":"10.1016\/j.amjcard.2007.03.005","article-title":"Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial","volume":"99","author":"Cushman","year":"2007","journal-title":"American Journal of Cardiology"},{"issue":"9118","key":"10.1002\/14651858.CD010315.pub5-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD010315.pub5-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3109\/08037059709062088","article-title":"The Hypertension Optimal Treatment (HOT) Study: 24-month data on blood pressure and tolerability","volume":"6","author":"Hansson","year":"1997","journal-title":"Blood Pressure"},{"issue":"5","key":"10.1002\/14651858.CD010315.pub5-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3109\/08037059409102281","article-title":"The Hypertension Optimal Treatment (HOT) Study \u2013 patient characteristics: randomization, risk profiles, and early blood pressure results","volume":"3","author":"Hansson","year":"1994","journal-title":"Blood Pressure"},{"issue":"1","key":"10.1002\/14651858.CD010315.pub5-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3109\/08037059309077529","article-title":"The Hypertension Optimal Treatment Study (the HOT Study)","volume":"2","author":"Hansson","year":"1993","journal-title":"Blood Pressure"},{"issue":"4","key":"10.1002\/14651858.CD010315.pub5-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1097\/01.hjh.0000052482.18130.b2","article-title":"Benefits and risks of more intensive blood pressure lowering in hypertensive patients of the HOT study with different risk profiles: does a J-shaped curve exist in smokers?","volume":"21","author":"Zanchetti","year":"2003","journal-title":"Journal of Hypertension"},{"issue":"6","key":"10.1002\/14651858.CD010315.pub5-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/00004872-200106000-00021","article-title":"Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study. HOT Study Group","volume":"19","author":"Zanchetti","year":"2001","journal-title":"Journal of Hypertension"},{"key":"10.1002\/14651858.CD010315.pub5-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1471-2261-10-37","article-title":"Protocol for PAST BP: a randomised controlled trial of different blood pressure targets for people with a history of stroke of transient ischaemic attack (TIA) in primary care","volume":"10","author":"Fletcher","year":"2010","journal-title":"BMC Cardiovascular Disorders"},{"key":"10.1002\/14651858.CD010315.pub5-BIB0016|cit16","first-page":"627","article-title":"RCT of different systolic blood pressure targets for people with a history or stroke or transient ischaemic attack: the PAST-BP (Prevention After Stroke \u2013 Blood Pressure) study","volume":"28","author":"Mant","year":"2014","journal-title":"Journal of Human Hypertension"},{"key":"10.1002\/14651858.CD010315.pub5-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"i708","DOI":"10.1136\/bmj.i708","article-title":"Different systolic blood pressure targets for people with history of stroke or transient ischaemic attack: PAST-BP (Prevention After Stroke \u2013 Blood Pressure) randomised controlled trial","volume":"352","author":"Mant","year":"2016","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/14651858.CD010315.pub5-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1001\/jamaneurol.2017.5153","article-title":"Effect of standard vs intensive blood pressure control on cerebral blood flow in small vessel disease. The PRESERVE randomized clinical trial","volume":"75","author":"Croall","year":"2018","journal-title":"JAMA Neurology"},{"key":"10.1002\/14651858.CD010315.pub5-BIB0019|cit19","unstructured":"How intensively should we treat blood PRESsure in established cERebral small VEssel disease? www.isrctn.com\/ISRCTN37694103"},{"key":"10.1002\/14651858.CD010315.pub5-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1161\/STROKEAHA.120.032054","article-title":"PRESERVE. Randomized trial of intensive versus standard blood pressure control in small vessel disease","volume":"52","author":"Markus","year":"2021","journal-title":"Stroke"},{"issue":"5","key":"10.1002\/14651858.CD010315.pub5-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1177\/1740774514537404","article-title":"The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT)","volume":"11","author":"Ambrosius","year":"2014","journal-title":"Clinical Trials"},{"issue":"22","key":"10.1002\/14651858.CD010315.pub5-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Williamson","year":"2015","journal-title":"New England Journal of Medicine"},{"issue":"24","key":"10.1002\/14651858.CD010315.pub5-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1001\/jama.2016.7050","article-title":"Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged \u226575 years: a randomized clinical trial","volume":"315","author":"Williamson","year":"2016","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD010315.pub5-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1747-4949.2010.00573.x","article-title":"The Secondary Prevention of Small Subcortical Strokes (SPS3) study","volume":"6","author":"Benavente","year":"2011","journal-title":"International Journal of Stroke"},{"issue":"5","key":"10.1002\/14651858.CD010315.pub5-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1177\/1740774516643689","article-title":"A post hoc evaluation of a sample size re-estimation in the Secondary Prevention of Small Subcortical Strokes study","volume":"13","author":"McClure","year":"2016","journal-title":"Clinical Trials"},{"issue":"9891","key":"10.1002\/14651858.CD010315.pub5-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(13)60852-1","article-title":"Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial","volume":"382","author":"Benavente","year":"2013","journal-title":"Lancet"},{"issue":"9","key":"10.1002\/14651858.CD010315.pub5-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/00004872-198809000-00002","article-title":"The BBB study: a prospective randomized study of intensified antihypertensive treatment","volume":"6","author":"BBB Study Group","year":"1988","journal-title":"Journal of Hypertension"},{"issue":"4","key":"10.1002\/14651858.CD010315.pub5-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3109\/08037059409102265","article-title":"The BBB study: the effect of intensified antihypertensive treatment on the level of blood pressure, side-effects, morbidity and mortality in \"well-treated\" hypertensive patients. Behandla Blodtryck Battre","volume":"3","author":"Hannson","year":"1994","journal-title":"Blood Pressure"},{"issue":"Suppl 6","key":"10.1002\/14651858.CD010315.pub5-BIB0029|cit29","first-page":"329","article-title":"Hypertension control based on HOme Systolic Pressure (HOSP) study: design and interim report of the main study","volume":"24","author":"Kawano","year":"2006","journal-title":"Journal of Hypertension"},{"issue":"Suppl 6","key":"10.1002\/14651858.CD010315.pub5-BIB0030|cit30","first-page":"465","article-title":"HOSP study","volume":"64","author":"Kawano","year":"2006","journal-title":"Nihon Rinsho [Japanese Journal of Clinical Medicine]"},{"issue":"3","key":"10.1002\/14651858.CD010315.pub5-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.ahj.2012.11.008","article-title":"INtensive versus standard ambulatory blood pressure lowering to prevent functional DeclINe in the ElderlY (INFINITY)","volume":"165","author":"White","year":"2013","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD010315.pub5-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1161\/CIRCULATIONAHA.119.041603","article-title":"Effects of intensive versus standard ambulatory blood pressure control on cerebrovascular outcomes in older people (INFINITY)","volume":"140","author":"White","year":"2019","journal-title":"Circulation"},{"issue":"13","key":"10.1002\/14651858.CD010315.pub5-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJM199403313301301","article-title":"The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group","volume":"330","author":"Klahr","year":"1994","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD010315.pub5-BIB0034|cit34","unstructured":"Effect of intensive blood pressure control on progression of coronary atherosclerosis: randomized evaluation by intravascular ultrasound clinicaltrials.gov\/show\/NCT01230216"},{"key":"10.1002\/14651858.CD010315.pub5-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/1745-6215-14-401","article-title":"Prevention of Decline in Cognition after Stroke Trial (PODCAST): a study protocol for a factorial randomised controlled trial of intensive versus guideline lowering of blood pressure and lipids","volume":"14","author":"Blackburn","year":"2013","journal-title":"Trials"},{"issue":"9463","key":"10.1002\/14651858.CD010315.pub5-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(05)71082-5","article-title":"Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial","volume":"365","author":"Ruggenenti","year":"2005","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010315.pub5-BIB0037|cit37","first-page":"39","article-title":"Rationale of the REstart or STop Antithrombotics Randomised Trial in Asia Pacific (RESTART-AP)","volume":"36","author":"Arima","year":"2013","journal-title":"Cerebrovascular Diseases"},{"issue":"10","key":"10.1002\/14651858.CD010315.pub5-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJM199803053381003","article-title":"The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension","volume":"338","author":"Estacio","year":"1998","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD010315.pub5-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0197-2456(95)00154-9","article-title":"Baseline characteristics of participants in the Appropriate Blood Pressure Control in Diabetes trial","volume":"17","author":"Estacio","year":"1996","journal-title":"Controlled Clinical Trials"},{"issue":"1","key":"10.1002\/14651858.CD010315.pub5-BIB0040|cit40","first-page":"1","article-title":"The ABCD (Appropriate Blood Pressure Control in Diabetes) trial. Rationale and design of a trial of hypertension control (moderate or intensive) in type II diabetes","volume":"2","author":"Savage","year":"1993","journal-title":"Online Journal of Current Clinical Trials"},{"issue":"4","key":"10.1002\/14651858.CD010315.pub5-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/sj.jhh.1002313","article-title":"Randomized study of traditional versus aggressive systolic blood pressure control (Cardio-Sis): rationale, design and characteristics of the study population","volume":"22","author":"Verdecchia","year":"2008","journal-title":"Journal of Human Hypertension"},{"issue":"3","key":"10.1002\/14651858.CD010315.pub5-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1161\/HYPERTENSIONAHA.113.02089","article-title":"Tight versus standard blood pressure control in patients with hypertension with and without cardiovascular disease","volume":"63","author":"Reboldi","year":"2014","journal-title":"Hypertension"},{"issue":"9689","key":"10.1002\/14651858.CD010315.pub5-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S0140-6736(09)61340-4","article-title":"Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial","volume":"374","author":"Verdecchia","year":"2009","journal-title":"Lancet"},{"issue":"12","key":"10.1002\/14651858.CD010315.pub5-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1097\/HJH.0000000000002660","article-title":"Termination of the ESH-CHL-SHOT trial","volume":"38","author":"Liu","year":"2020","journal-title":"Journal of Hypertension"},{"issue":"9","key":"10.1002\/14651858.CD010315.pub5-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1097\/HJH.0000000000000254","article-title":"Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial","volume":"32","author":"Zanchetti","year":"2014","journal-title":"Journal of Hypertension"},{"issue":"11","key":"10.1002\/14651858.CD010315.pub5-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1001\/jamaneurol.2019.2167","article-title":"Effect of standard vs intensive blood pressure control on the risk of recurrent stroke. A randomized clinical trial and meta-analysis","volume":"76","author":"Kitagawa","year":"2019","journal-title":"JAMA Neurology"},{"key":"10.1002\/14651858.CD010315.pub5-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1097\/HJH.0000000000001784","article-title":"Intensive blood pressure control may not be safe in subacute ischemic stroke by intracranial atherosclerosis: a result of randomized trial","volume":"36","author":"Park","year":"2018","journal-title":"Journal of Hypertension"},{"key":"10.1002\/14651858.CD010315.pub5-BIB0048|cit48","unstructured":"Strategy of blood pressure intervention in the elderly hypertensive patients (STEP) clinicaltrials.gov\/show\/NCT03015311"},{"issue":"14","key":"10.1002\/14651858.CD010315.pub5-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1056\/NEJMoa2111437","article-title":"Trial of intensive blood-pressure control in older patients with hypertension","volume":"385","author":"Zhang","year":"2021","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD010315.pub5-BIB0050|cit50","first-page":"264","article-title":"Ten year target systolic blood pressure less than 120 mmHg for more than 65 aged hypertension patients with chronic renal disease","volume":"37","author":"Zeng","year":"2016","journal-title":"European Heart Journal Supplements"},{"key":"10.1002\/14651858.CD010315.pub5-BIB0051|cit51","unstructured":"Blood Pressure Control Target in Diabetes (BPROAD) clinicaltrials.gov\/ct2\/show\/NCT03808311"},{"key":"10.1002\/14651858.CD010315.pub5-BIB0052|cit52","unstructured":"European blood pressure intensive control after stroke (EPICS-Pilot) clinicaltrials.gov\/ct2\/show\/NCT04647292"},{"key":"10.1002\/14651858.CD010315.pub5-BIB0053|cit53","unstructured":"Effects of Intensive Systolic Blood Pressure Lowering Treatment in Reducing RIsk of Vascular evenTs (ESPRIT) clinicaltrials.gov\/ct2\/show\/NCT04030234"},{"key":"10.1002\/14651858.CD010315.pub5-BIB0054|cit54","unstructured":"Intensive Blood Pressure Intervention in Stroke (IBIS) trial clinicaltrials.gov\/ct2\/show\/NCT03585595"},{"key":"10.1002\/14651858.CD010315.pub5-BIB0055|cit55","unstructured":"Study to evaluate the effect on improvement of LVH by the control of BP in hypertension patients with AV disease clinicaltrials.gov\/ct2\/show\/NCT03666351"},{"key":"10.1002\/14651858.CD010315.pub5-BIB0056|cit56","unstructured":"OPtimal blood pressure for the prevenTIon of Major vAscuLar Events in patients with DIABETES Mellitus (OPTIMAL-DIABETES) clinicaltrials.gov\/ct2\/show\/NCT04040634"},{"key":"10.1002\/14651858.CD010315.pub5-BIB0057|cit57","unstructured":"OPtimal blood pressure for the prevenTIon of Major vAscuLar Events in Stroke Patients (OPTIMAL Stroke) clinicaltrials.gov\/ct2\/show\/NCT04036409"},{"key":"10.1002\/14651858.CD010315.pub5-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"S0735","DOI":"10.1016\/j.jacc.2017.11.006","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults","volume":"17","author":"Whelton","year":"2017","journal-title":"Journal of the American College of Cardiology"},{"issue":"21","key":"10.1002\/14651858.CD010315.pub5-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1161\/circulationaha.107.183885","article-title":"Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Council on Clinical Cardiology and Epidemiology and Prevention","volume":"115","author":"Rosendorff","year":"2007","journal-title":"Circulation"},{"issue":"10","key":"10.1002\/14651858.CD010315.pub5-BIB0060|cit60","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008277.pub2","article-title":"Blood pressure targets for hypertension in people with diabetes mellitus","author":"Arguedas","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD010315.pub5-BIB0061|cit61","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004349.pub3","article-title":"Blood pressure targets in adults with hypertension","author":"Arguedas","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD010315.pub5-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/eurheartj\/ehy337","article-title":"J-curves in hypertension: what do they tell us about treatment of high blood pressure?","volume":"0","author":"Auer","year":"2018","journal-title":"European Heart Journal"},{"issue":"23","key":"10.1002\/14651858.CD010315.pub5-BIB0063|cit63","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1093\/eurheartj\/ehq328","article-title":"J-curve revisited: an analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) trial","volume":"31","author":"Bangalore","year":"2010","journal-title":"European Heart Journal"},{"issue":"24","key":"10.1002\/14651858.CD010315.pub5-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1161\/CIRCULATIONAHA.110.016337","article-title":"Blood pressure targets in subjects with type 2 diabetes mellitus\/impaired fasting glucose: observations from traditional and Bayesian random-effects meta-analyses of randomized trials","volume":"123","author":"Bangalore","year":"2011","journal-title":"Circulation"},{"issue":"9","key":"10.1002\/14651858.CD010315.pub5-BIB0065|cit65","first-page":"601","article-title":"Blood pressure targets in patients with coronary artery disease: observations from traditional and Bayesian random effects meta-analysis of randomised trials","volume":"99","author":"Bangalore","year":"2013","journal-title":"Heart (British Cardiac Society)"},{"issue":"6","key":"10.1002\/14651858.CD010315.pub5-BIB0066|cit66","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.amjmed.2017.01.004","article-title":"Optimal systolic blood pressure target after SPRINT: insights from a network meta-analysis of randomized trials","volume":"130","author":"Bangalore","year":"2017","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD010315.pub5-BIB0067|cit67","doi-asserted-by":"publisher","first-page":"f5680","DOI":"10.1136\/bmj.f5680","article-title":"Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials","volume":"347","author":"Ninomiya","year":"2013","journal-title":"BMJ"},{"issue":"9943","key":"10.1002\/14651858.CD010315.pub5-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S0140-6736(14)61212-5","article-title":"Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data","volume":"384","author":"Blood Pressure Lowering Treatment Trialists' Collaboration","year":"2014","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD010315.pub5-BIB0069|cit69","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1016\/S0140-6736(21)00590-0","article-title":"Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis","volume":"397","author":"Blood Pressure Lowering Treatment Trialists' Collaboration","year":"2021","journal-title":"Lancet"},{"issue":"10017","key":"10.1002\/14651858.CD010315.pub5-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S0140-6736(15)00816-8","article-title":"Lower blood pressure targets: to whom do they apply?","volume":"387","author":"Brunstr\u00f6m","year":"2016","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD010315.pub5-BIB0071|cit71","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1161\/HYPERTENSIONAHA.120.14647","article-title":"Evidence for the universal blood pressure goal of <130\/80 mm Hg is strong: controversies in hypertension \u2013 pro side of the argument","volume":"76","author":"Carey","year":"2020","journal-title":"Hypertension"},{"issue":"5","key":"10.1002\/14651858.CD010315.pub5-BIB0072|cit72","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.cjca.2015.02.016","article-title":"The 2015 Canadian Hypertension Education Program. Recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension","volume":"31","author":"Daskalopoulou","year":"2015","journal-title":"Canadian Journal of Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD010315.pub5-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1161\/CIR.0b013e31821d9ef2","article-title":"ACCF\/AHA\/AMA-PCPI 2011 performance measures for adults with coronary artery disease and hypertension: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement","volume":"124","author":"Messer","year":"2011","journal-title":"Circulation"},{"issue":"29","key":"10.1002\/14651858.CD010315.pub5-BIB0074|cit74","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","article-title":"2016 European Guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice","volume":"37","author":"Piepoli","year":"2016","journal-title":"European Heart Journal"},{"issue":"1","key":"10.1002\/14651858.CD010315.pub5-BIB0075|cit75","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/eurjpc\/zwab154","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"29","author":"Visseren","year":"2022","journal-title":"European Heart Journal"},{"issue":"6","key":"10.1002\/14651858.CD010315.pub5-BIB0076|cit76","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1097\/hjh.0b013e328333146d","article-title":"Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document","volume":"18","author":"Mancia","year":"2009","journal-title":"Journal of Hypertension"},{"issue":"12","key":"10.1002\/14651858.CD010315.pub5-BIB0077|cit77","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1093\/eurheartj\/ehm236","article-title":"2007 Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"28","author":"Mancia","year":"2007","journal-title":"European Heart Journal"},{"issue":"28","key":"10.1002\/14651858.CD010315.pub5-BIB0078|cit78","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","article-title":"2013 ESH\/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"34","author":"Mancia","year":"2013","journal-title":"European Heart Journal"},{"issue":"33","key":"10.1002\/14651858.CD010315.pub5-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"European Heart Journal"},{"issue":"10022","key":"10.1002\/14651858.CD010315.pub5-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis","volume":"387","author":"Ettehad","year":"2016","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD010315.pub5-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1001\/jama.1991.03460040065031","article-title":"The J-curve phenomenon and the treatment of hypertension. Is there a point beyond which pressure reduction is dangerous?","volume":"265","author":"Farnett","year":"1991","journal-title":"JAMA"},{"issue":"7","key":"10.1002\/14651858.CD010315.pub5-BIB0082|cit82","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.jash.2014.05.002","article-title":"Lowering blood pressure to prevent stroke recurrence: a systematic review of long-term randomized trials","volume":"8","author":"Feldstein","year":"2014","journal-title":"Journal of the American Society of Hypertension"},{"issue":"2","key":"10.1002\/14651858.CD010315.pub5-BIB0083|cit83","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3949\/ccjm.78a.10101","article-title":"Goal-directed antihypertensive therapy: lower may not always be better","volume":"78","author":"Filippone","year":"2011","journal-title":"Cleveland Clinic Journal of Medicine"},{"issue":"10159","key":"10.1002\/14651858.CD010315.pub5-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","article-title":"Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"GBD 2017 Causes of Death Collaborators","year":"2018","journal-title":"Lancet"},{"issue":"10159","key":"10.1002\/14651858.CD010315.pub5-BIB0085|cit85","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/S0140-6736(18)32225-6","article-title":"Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"GBD 2017 Risk Factor Collaborators","year":"2018","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD010315.pub5-BIB0086|cit86","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane 2022 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD010315.pub5-BIB0087|cit87","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.cjca.2020.02.086","article-title":"Hypertension Canada's 2020 comprehensive guidelines for the prevention, diagnosis, risk assessment, and treatment of hypertension in adults and children","volume":"36","author":"Rabi","year":"2020","journal-title":"Canadian Journal of Cardiology"},{"key":"10.1002\/14651858.CD010315.pub5-BIB0088|cit88","unstructured":"European Medicines Agency Clinical safety data management: definitions and standards for expedited reporting (CPMP\/ICH\/377\/95), 1995 www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/09\/WC500002749.pdf"},{"issue":"19","key":"10.1002\/14651858.CD010315.pub5-BIB0089|cit89","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 Report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD010315.pub5-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD010315.pub5-BIB0091|cit91","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1161\/HYPERTENSIONAHA.120.14648","article-title":"Evidence for the universal blood pressure goal of <130\/80 mm Hg is strong: controversies in hypertension \u2013 con side of the argument","volume":"76","author":"Kaul","year":"2020","journal-title":"Hypertension"},{"issue":"7","key":"10.1002\/14651858.CD010315.pub5-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","article-title":"Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"Kernan","year":"2014","journal-title":"Stroke"},{"issue":"9362","key":"10.1002\/14651858.CD010315.pub5-BIB0093|cit93","first-page":"1903","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD010315.pub5-BIB0094|cit94","doi-asserted-by":"publisher","first-page":"64","DOI":"10.12809\/hkmj187701","article-title":"Update on the Hong Kong Reference Framework for Hypertension Care for Adults in Primary Care Settings \u2013 review of evidence on the definition of high blood pressure and goal of therapy","volume":"25","author":"Lim","year":"2019","journal-title":"Hong Kong Medical Journal"},{"issue":"8","key":"10.1002\/14651858.CD010315.pub5-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"e1001293","DOI":"10.1371\/journal.pmed.1001293","article-title":"Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysis","volume":"9","author":"Lv","year":"2012","journal-title":"PLOS Medicine"},{"issue":"11","key":"10.1002\/14651858.CD010315.pub5-BIB0096|cit96","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1503\/cmaj.121468","article-title":"Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis","volume":"185","author":"Lv","year":"2013","journal-title":"Canadian Medical Association Journal"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD010315.pub5-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"S304","DOI":"10.2337\/dc11-s244","article-title":"Antihypertensive treatment and blood pressure in diabetic and nondiabetic patients: the lower, the better?","volume":"34","author":"Mancia","year":"2011","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1002\/14651858.CD010315.pub5-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/HYPERTENSIONAHA.113.01922","article-title":"Aggressive blood pressure lowering is dangerous: the J-curve: pro side of the argument","volume":"63","author":"Mancia","year":"2014","journal-title":"Hypertension"},{"issue":"17","key":"10.1002\/14651858.CD010315.pub5-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1001\/archinternmed.2012.3147","article-title":"Intensive and standard blood pressure targets in patients with type 2 diabetes mellitus: systematic review and meta-analysis","volume":"172","author":"McBrien","year":"2012","journal-title":"Archives of Internal Medicine"},{"issue":"12","key":"10.1002\/14651858.CD010315.pub5-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"884","DOI":"10.7326\/0003-4819-144-12-200606200-00005","article-title":"Dogma disputed: can aggressively lowering pressure in hypertensive patients with coronary artery disease be dangerous?","volume":"144","author":"Messerli","year":"2006","journal-title":"Annals of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD010315.pub5-BIB0101|cit101","first-page":"e29","article-title":"Heart disease and stroke statistics \u2013 2015 update: a report from the American Heart Association","volume":"131","author":"Mozaffarian","year":"2015","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD010315.pub5-BIB0102|cit102","unstructured":"National Institute for Heath and Care Excellence Hypertension in adults: diagnosis and management www.nice.org.uk\/guidance\/ng136"},{"key":"10.1002\/14651858.CD010315.pub5-BIB0103|cit103","unstructured":"Reboussin DM Random sequence generation method in SPRINT [personal communication] E-mail to: LC Saiz"},{"key":"10.1002\/14651858.CD010315.pub5-BIB0104|cit104","unstructured":"Review Manager 5 (RevMan 5) Nordic Cochrane Centre, The Cochrane Collaboration 2014"},{"issue":"4","key":"10.1002\/14651858.CD010315.pub5-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/HCO.0b013e32832bfb48","article-title":"Evidence for a lower target blood pressure for people with heart disease","volume":"24","author":"Rosendorff","year":"2009","journal-title":"Current Opinion in Cardiology"},{"issue":"6","key":"10.1002\/14651858.CD010315.pub5-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1161\/HYP.0000000000000018","article-title":"Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension","volume":"65","author":"Rosendorff","year":"2015","journal-title":"Hypertension"},{"issue":"2","key":"10.1002\/14651858.CD010315.pub5-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s11883-010-0094-7","article-title":"Evidence for aggressive blood pressure-lowering goals in patients with coronary artery disease","volume":"12","author":"Roy","year":"2010","journal-title":"Current Atherosclerosis Reports"},{"issue":"17","key":"10.1002\/14651858.CD010315.pub5-BIB0108|cit108","doi-asserted-by":"publisher","first-page":"9348","DOI":"10.3390\/ijerph18179348","article-title":"Systolic blood pressure and outcomes in stable outpatients with recent symptomatic artery disease: a population-based longitudinal study","volume":"18","author":"S\u00e1nchez","year":"2021","journal-title":"International Journal of Environmental Research and Public Health"},{"key":"10.1002\/14651858.CD010315.pub5-BIB0109|cit109","unstructured":"Moderately elevated blood pressure. A systematic literature review. Swedish Council on Health Technology Assessment in Health Care (SBU); 2007. SBU report no 170 www.sbu.se\/en\/publications\/sbu-assesses\/moderately-elevated-blood-pressure\/"},{"issue":"42","key":"10.1002\/14651858.CD010315.pub5-BIB0110|cit110","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.1093\/eurheartj\/ehw334","article-title":"Cardiovascular disease in Europe: epidemiological update 2016","volume":"37","author":"Townsend","year":"2016","journal-title":"European Heart Journal"},{"issue":"8","key":"10.1002\/14651858.CD010315.pub5-BIB0111|cit111","doi-asserted-by":"publisher","first-page":"541","DOI":"10.7326\/0003-4819-154-8-201104190-00335","article-title":"Systematic review: blood pressure target in chronic kidney disease and proteinuria as an effect modifier","volume":"154","author":"Upadhyay","year":"2011","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD010315.pub5-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1161\/HYPERTENSIONAHA.113.01018","article-title":"Aggressive blood pressure lowering is dangerous: the J-curve: con side of the argument","volume":"63","author":"Verdecchia","year":"2014","journal-title":"Hypertension"},{"key":"10.1002\/14651858.CD010315.pub5-BIB0113|cit113","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1161\/HYPERTENSIONAHA.116.07608","article-title":"More versus less intensive blood pressure-lowering strategy. Cumulative evidence and trial sequential analysis","volume":"68","author":"Verdecchia","year":"2016","journal-title":"Hypertension"},{"issue":"10056","key":"10.1002\/14651858.CD010315.pub5-BIB0114|cit114","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1016\/S0140-6736(16)31326-5","article-title":"Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study","volume":"388","author":"Vidal-Petiot","year":"2016","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD010315.pub5-BIB0115|cit115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/eurheartj\/ehy488","article-title":"Potential impact of the 2017 ACC\/AHA guideline on high blood pressure in normotensive patients with stable coronary artery disease: insights from the CLARIFY registry","volume":"0","author":"Vidal-Petiot","year":"2018","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD010315.pub5-BIB0116|cit116","unstructured":"World Health Organization Guideline for the pharmacological treatment of hypertension in adults apps.who.int\/iris\/bitstream\/handle\/10665\/344424\/9789240033986-eng.pdf"},{"issue":"10017","key":"10.1002\/14651858.CD010315.pub5-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0140-6736(15)00805-3","article-title":"Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis","volume":"387","author":"Xie","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD010315.pub5-BIB0118|cit118","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010315","article-title":"Blood pressure targets for the treatment of patients with hypertension and cardiovascular disease","author":"Gorricho","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD010315.pub5-BIB0119|cit119","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010315.pub2","article-title":"Blood pressure targets for the treatment of people with hypertension and cardiovascular disease","author":"Saiz","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD010315.pub5-BIB0120|cit120","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010315.pub4","article-title":"Blood pressure targets for the treatment of people with hypertension and cardiovascular disease","author":"Saiz","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T15:48:15Z","timestamp":1730994495000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010315.pub5"}},"subtitle":[],"editor":[{"name":"Cochrane Hypertension Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,11,18]]},"references-count":120,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010315.pub5","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,18]]}}}